The Pharma Data

DECEMBER 17, 2020

An Fc-engineered monoclonal antibody targeting the HER2 oncoprotein, MARGENZA offers hope for patients who have received two or more prior anti-HER2 regimens, with at least one being for metastatic disease. When Pigs Fly Allergy-friendly.

FDA Approval 52

FDA Approval Genomics Genome Production 52

Scienmag

SEPTEMBER 15, 2020

15, 2020 — Initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggest that following Arizona’s first reported case of COVID-19 in late January, the state experienced no cases that went undetected […]. — Sept.

Genome 40

Genome Genomics Allergies Genetics 40

Roots Analysis

MARCH 16, 2023

The IVT mRNAs are structurally similar to natural mRNAs, these synthetic mRNAs can be used to express proteins through genetic engineering. mRNA drugs are considered to offer an effective alternative to gene therapies, specifically for protein replacement, as they avoid the risk of genome integration and offer strong transient expression.

Vaccine 52

Vaccine Vaccination DNA Protein 52

XTalks

NOVEMBER 30, 2023

These dual gRNAs target three specific sites within the HIV genome, facilitating the removal of substantial portions of the viral DNA and minimizing the potential for viral escape. The noteworthy candidate, EBT-101, is designed to eliminate HIV proviral DNA using CRISPR-Cas9 along with two guide RNAs (gRNAs).

FDA Approval 111

FDA Approval Gene Therapy Clinical Trials Clinical Trials 111

XTalks

MARCH 18, 2024

The precision fermentation study highlights how genetically engineered microorganisms can inhibit the growth of foodborne pathogens. The study proposes a new system for categorizing genetically engineered products to improve public perception and acceptance.

Genetic Engineering 52

Genetic Engineering Genetics Production Protein 52

Delveinsight

AUGUST 27, 2020

The phase 1 study that is being run by the National Institute of Allergy and Infectious Diseases tests three dose levels of the vaccine, mRNA-1273, given in two injections a month apart in 120 adults. Moderna showed robust phase 1 results for its COVID-19 vaccine in adults up to 55 last month.

Vaccination 53

Vaccination Vaccine Research Trials 53

The Pharma Data

FEBRUARY 22, 2021

Thanks to its R&D agreement with Pairwise , the Broad Institute and others, Bayer has access to the best genome editing tools. Bayer’s research collaboration with the French biotech company Meiogenix is also accelerating the development of proprietary technologies related to plant breeding and genome editing applications.

Gene Editing 40

Gene Editing Genomics Genome Protein 40